NIAGEN BIOSCIENCE, INC. Capital Leases, Future Minimum Payments Due in Two Years
NIAGEN BIOSCIENCE, INC. (NAGE) had Capital Leases, Future Minimum Payments Due in Two Years of $32.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2021-03-12
- 2020-12-31: Capital Leases, Future Minimum Payments Due in Two Years $32.00K.
- 2020-09-30: Capital Leases, Future Minimum Payments Due in Two Years $32.00K.
- 2020-06-30: Capital Leases, Future Minimum Payments Due in Two Years $32.00K.
- 2020-03-31: Capital Leases, Future Minimum Payments Due in Two Years $29.00K.
| Period end | Capital Leases, Future Minimum Payments Due in Two Years |
|---|---|
| 2020-12-31 | $32.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | $32.00K 10-Q · filed 2020-11-04 |
| 2020-06-30 | $32.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $29.00K 10-Q · filed 2020-05-18 |
| 2019-12-31 | $18.00K 10-K · filed 2020-03-10 |
| 2019-09-30 | $272.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $272.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $126.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $126.00K 10-K · filed 2019-03-07 |
| 2017-12-30 | $196.00K 10-K · filed 2018-03-15 |
| 2016-12-31 | $249.00K 10-K · filed 2017-03-16 |
| 2016-01-02 | $246.75K 10-K · filed 2016-03-17 |
| 2015-01-03 | $178.56K 10-K · filed 2015-03-19 |
| 2013-12-28 | $112.79K 10-K · filed 2014-03-27 |
| 2012-12-29 | $97.95K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |